Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2020 Financial Results and Provide Corporate Update

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq: XENE) plans to report its first quarter 2020 financial and operating results on May 21, 2020, after U.S. markets close. Following this, a conference call and audio webcast will be held at 4:30 PM ET to discuss the results and provide a corporate update. Interested participants can join by dialing (855) 779-9075 or (631) 485-4866 for international callers, using conference ID 8385218. The webcast will be available for replay for 30 days on Xenon's website.

BURNABY, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2020 financial and operating results after the close of U.S. financial markets on Thursday, May 21, 2020.  Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) to discuss the results and to provide a corporate update.

To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 8385218. The webcast will be broadcast live on the “Investors” section of Xenon's website at www.xenon-pharma.com and will be available for replay following the call for 30 days.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

 

FAQ

When will Xenon Pharmaceuticals report its first quarter 2020 results?

Xenon Pharmaceuticals will report its first quarter 2020 financial and operating results on May 21, 2020.

What time is the Xenon Pharmaceuticals conference call?

The conference call will take place at 4:30 PM Eastern Time on May 21, 2020.

How can I participate in the Xenon Pharmaceuticals conference call?

To participate, dial (855) 779-9075 or (631) 485-4866 for international callers and provide conference ID 8385218.

Where can I find the Xenon Pharmaceuticals webcast?

The webcast will be available on the 'Investors' section of Xenon's website and will be replayable for 30 days.